Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels are transmembrane ion channels responsible for the initiation and propagation of action potentials in excitable cells such as neurons and muscle. Local anesthetic drugs, such as lidocaine and bupivacaine, bind reversibly to the cytoplasmic portion of these channels in their open or inactivated states, blocking sodium influx and thus inhibiting action potential propagation. This leads to a loss of sensation in the innervated area. Local anesthetics show use-dependent (phasic) block, acting more strongly when neurons are firing rapidly. These agents display variable potency, onset, and duration of action depending on their lipophilicity, protein binding, and chemical structure. Systemic absorption or overdose can cause CNS and cardiac toxicity.
Blockade of voltage-gated sodium channels leading to reversible inhibition of action potential generation and conduction in excitable tissues
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein (Voltage-gated sodium channel; alpha subunit).